Onderzoeker
Geert Leroux-Roels
- Trefwoorden:influenza, toegepaste immunologie, Vaccinologie
- Disciplines:Infectieziekten, Vaccinologie, Virologie, Toegepaste immunologie
Affiliaties
- Vakgroep Diagnostische Wetenschappen (Departement)
Lid
Vanaf1 okt 2018 → Heden - Vakgroep Klinische Biologie, Microbiologie en Immunologie (Departement)
Verantwoordelijke
Vanaf1 okt 2013 → 30 sep 2017 - Vakgroep Klinische Biologie, Microbiologie en Immunologie (Departement)
Lid
Vanaf1 okt 2013 → 30 sep 2017 - Raad van Bestuur/Bestuurscollege (Administratieve eenheid)
Lid
Vanaf1 okt 2008 → 30 sep 2014 - Vakgroep Klinische Biologie, Microbiologie en Immunologie (Departement)
Lid
Vanaf1 okt 1997 → 30 sep 2018
Projecten
1 - 2 of 2
- BIOVACSAFE – Biomerkers voor verbeterde vaccinveiligheidVanaf1 mrt 2012 → 31 aug 2018Financiering: Andere Eu-programma's en intiatieven
- Studie van de mechanismen van hepatitis C virus transmissie en klinische toepassingenVanaf1 jan 2012 → 31 okt 2018Financiering: BOF - Geconcert. Onderzoeksacties vanaf 1994
Publicaties
1 - 10 van 89
- Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine(2023)
Auteurs: Isabel Leroux-Roels, Jacques Bruhwyler, Lilli Stergiou, Mark Sumeray, Cathy Maes, Paul-Henri Lambert, Geert Leroux-Roels
- Human immunity and susceptibility to influenza A(H3) viruses of avian, equine, and swine origin(2023)
Auteurs: Elien Vandoorn, Wojciech Stadejek, Isabel Leroux-Roels, Geert Leroux-Roels, Anna Parys, Kristien Van Reeth
Pagina's: 98 - 109 - Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium(2022)
Auteurs: Sarah Begue, Gwenn Waerlop, Bruno Salaun, Michel Janssens, Duncan Bellamy, Rebecca Jane Cox, Richard Davies, Elena Gianchecchi, Donata Medaglini, Emanuele Montomoli, et al.
- Randomized, double-blind, reference-controlled, phase 2a study evaluating the immunogenicity and safety of OVX836, a nucleoprotein-based influenza vaccine(2022)
Auteurs: Isabel Leroux-Roels, Gwenn Waerlop, Jessika Tourneur, FIEN DE BOEVER, Catherine Maes, Jacques Bruhwyler, Delphine Guyon-Gellin, Philippe Moris, Judith Del Campo, Paul Willems, et al.
- Characterization of the cell-mediated immune response to TakedaU+2019s live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting(2022)
Auteurs: Vianney Tricou, Raphael Gottardo, Michael A. Egan, Frédéric Clement, Geert Leroux-Roels, Xavier Sáez-Llorens, Astrid Borkowski, Derek Wallace, Hansi J. Dean
Pagina's: 1143 - 1151 - Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium(2022)
Auteurs: Gwenn Waerlop, Geert Leroux-Roels, Teresa Lambe, Duncan Bellamy, Donata Medaglini, Elena Pettini, Rebecca Jane Cox, Mai-Chi Trieu, Richard Davies, Geir Bredholt, et al.
- The role of cell-mediated immunity against influenza and its implications for vaccine evaluation(2022)
Auteurs: Yorick Janssens, Gwenn Waerlop, Frédéric Clement, Geert Leroux-Roels, Isabel Leroux-Roels
- Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : a phase 1 randomized clinical trial(2021)
Auteurs: PG Kremsner, P Mann, A Kroidl, Isabel Leroux-Roels, C Schindler, JJ Gabor, M Schunk, Geert Leroux-Roels, JJ Bosch, R Fendel, et al.
Pagina's: 931 - 941 - Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT) : a randomised, double-blind, phase 3 trial(2021)
Auteurs: T Vesikari, JM Langley, N Segall, BJ Ward, C Cooper, G Poliquin, B Smith, S Gantt, JE McElhaney, M Dionne, et al.
Pagina's: 1271 - 1281 - Immunogenicity and safety of a 3-antigen hepatitis B vaccine vs a single-antigen hepatitis B vaccine : a phase 3 randomized clinical trial(2021)
Auteurs: T Vesikari, A Finn, P van Damme, Isabel Leroux-Roels, Geert Leroux-Roels, N Segall, A Toma, G Vallieres, R Aronson, D Reich, et al.